Koers NovAccess Global Inc. Other OTC
Aandelen
XSNX
US67001N1072
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 2,17 mln. 2,03 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -933K | Nettowinst (verlies) 2023 | -4 mln. -3,73 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,41 mln. 1,32 mln. | Nettoschuld 2023 | 2,36 mln. 2,2 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,16
x | K/w-verhouding 2023 |
-0,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 34,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 10-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Jason Anderson
BRD | Director/Board Member | 50 | 18-03-22 |
John Cassarini
CHM | Chairman | 57 | 14-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,67% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,63 mld. | |
-21,66% | 18,2 mld. | |
+29,96% | 12,01 mld. | |
-1,57% | 11,76 mld. | |
+16,03% | 10,4 mld. | |
-4,80% | 9,94 mld. |